Preclinical studies show Semax can modulate learning and memory through regulation of the BDNFTrkB signaling pathway (PMID: 16996037) Optic Nerve Disease: Approved for glaucomatous optic neuropathy and has been studied as an adjunct neuroprotective therapy (PMID: 11569188) ADHD Research: Studies suggest benefits for attention and hyperactivity symptoms (PMID: 16996699) Selank Clinical Experience (Russia) Selank has Russian clinical approval and research history: Generalized Anxiety: Approved in Russia for anxiety and stress-related disorders
Over 100,000 IVs Administered Hospital-experienced, fully licensed and insured nurses
Journal of Veterinary Medicine, 50 , 412416
This weight reduction is particularly beneficial for non-diabetic individuals as well, helping to lower the risk of developing obesity-related conditions
Reljanovic M, Reichel G, Rett K, et al
Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, Joles JA